Claim Missing Document
Check
Articles

Found 5 Documents
Search

Re-Emergence of Ampicillin Sensitive Salmonella Typhi and the Increase of Ciprofloxacin Resistance in Typhoid Fever Treatment in Asia: A Systematic Review Tanjaya, Felicity; Nathan, Johan; Nainggolan, Ita Margaretha; Moehario, Lucky; Thantry, Anita Devi Krishnan; Tunru, Andi Miyanza Lakipadada; Sean, Sherlyn
Indonesian Journal of Tropical and Infectious Disease Vol. 12 No. 1 (2024)
Publisher : Institute of Topical Disease Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/ijtid.v12i1.42305

Abstract

Typhoid fever is a disease caused by Salmonella Typhi infection. In 2000, 2.16 million people were affected worldwide, with more than 90% morbidity and mortality in Asia. Ampicillin is the first-line antibiotic used for typhoid management. However, the rise in resistance to first-line antibiotics has shifted ciprofloxacin as an alternative.  This study aimed to describe the trends in ciprofloxacin- and ampicillin-resistant Salmonella Typhi in Asia. This study was a systematic review that conformed to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. Search was indicated toward studies on Salmonella Typhi susceptibility toward ciprofloxacin and ampicillin were identified using PubMed, Cochrane Library, and ProQuest. Of the 1542 studies found, only 16 fulfilled the criteria. In 1996, Salmonella Typhi was not found to be resistant to ciprofloxacin, whereas 3.5% was resistant to ampicillin. In 2005, ciprofloxacin resistance increased to 19.3%, whereas ampicillin resistance decreased to 13.3%. In 2005-2014, a larger number of Salmonella Typhi isolates resistant to ciprofloxacin than to ampicillin. Furthermore, during 2016-2019, resistance to ciprofloxacin increased from 8.1% to 95%, while ampicillin resistance increased from 27.5% to 85.2%. This the high ampicillin resistance in South and East Asia. In Asia, there was an increase in ciprofloxacin-resistant Salmonella typhi from 1996 to 2019, whereas ampicillin-resistant Salmonella Typhi decreased from 1996 to 2015.  Between 2016 and 2019, contrasting evidence was found in East Asia and South Asia, where resistance toward ampicillin increased.
Appropriate Concentration of Curcumin as a Growth Factor in Neural Stem Cells Novianti, Titta; Kurniawan, Muhamad Panji Januarsyah; Nainggolan, Ita M
Al-Hayat: Journal of Biology and Applied Biology Vol. 7 No. 2 (2024)
Publisher : Fakultas Sains dan Teknologi, UIN Walisongo Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21580/ah.v7i2.20862

Abstract

The growth of Neural Stem Cell (NSC) in adult organisms is limited. Therefore, growth factors are needed to stimulate NSC cell proliferation and differentiation. Herbal Curcumin may be a growth factor. We promoted the growth of Cryopreserved Rat Cortical NSC cells with Curcumin (0.1 µM; 0.5 µM; 1 µM; 2 µM), DMSO, and synthetic growth factors (bFGF, TGF, and heparin). We analyzed the proliferation ability of NSCs by WST-1 assay, cell morphology, and expression of NCS cell marker genes (Nestin, MAP, and Sox2). Morphological analysis showed that cells reproduced optimally at 0.5 µM. The one-way ANOVA and Tukey's posthoc test on the WST-1 test showed significant differences between 0.5 µMCurcumin and other treatment groups. Sox2, MAP-2, and Nestin gene expression peaked at 0.5 µM. The appropriate concentration of Curcumin to stimulate NSC proliferation is 0.5 µM. Herbal extract curcumin has the same effect as commercial growth factors and can substitute synthetic growth factors. Curcumin acts as a growth factor that stimulates the proliferation of mouse NSCs.
Potential of Secretome Hydrogel for Wound Healing in LPS- and Scratch-Induced BJ Cells as an Inflammation Model Widowati, Wahyu; Rahmat, Deni; Faried, Ahmad; Nainggolan, Ita Margaretha; Priyandoko, Didik; Wargasetia, Teresa Liliana; Sugiaman, Vinna Kurniawati; Triharsiwi, Dwi Nur; Qlintang, Sandy; Murti, Harry; Azis, Rizal; Jeffrey, Jeffrey
Science and Technology Indonesia Vol. 10 No. 4 (2025): October
Publisher : Research Center of Inorganic Materials and Coordination Complexes, FMIPA Universitas Sriwijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26554/sti.2025.10.4.1242-1254

Abstract

Wound healing often requires specialized interventions to accelerate recovery due to prolonged inflammation and limited regenerative factors. Umbilical Cord Mesenchymal Stem Cells secretome (UCMSCs) comprises various cytokines and growth factors that can promote wound healing. This study aims to analyze the potential of a secretome-based hydrogel as a wound-healing agent using BJ fibroblast cells induced by lipopolysaccharide (LPS) and scratch injury as an inflammation model. The secretome hydrogel was formulated using Carbopol, Hydroxypropyl Methylcellulose (HPMC), Hydroxyethyl Cellulose (HEC), and secretome. Cytotoxicity was conducted using the WST-8 assay, while cell migration was evaluated through a scratch assay. Tumor Necrosis Factor-???? (TNF-????), Nuclear Factor kappa-B (NF-????B), and Interleukin-8 (IL-8) gene expression were analyzed via qRT-PCR. Additionally, malondialdehyde (MDA) levels were measured for oxidative stress assessment, whereas Connective Tissue Growth Factor (CTGF) and Transforming Growth Factor-????1 (TGF-????1) levels were quantified using ELISA and colorimetric assays. The secretome hydrogel exhibited no cytotoxic effects on BJ fibroblast cells and significantly enhanced cell migration. Moreover, it reduced the TNF-????, IL-8, and NF-????B expression, indicating anti-inflammatory activity. The hydrogel also decreased MDA levels while increasing TGF-β1 and CTGF expression, suggesting antioxidant properties and enhanced tissue regeneration in the inflammatory model. The secretome-based hydrogel presents a promising therapeutic approach for promoting chronic wound healing by modulating inflammation, reducing oxidative stress, enhancing tissue regeneration, and stimulating fibroblast migration.
Effectiveness of azithromycin and ciprofloxacin in the treatment of typhoid fever: a systematic review Mulyono, Bethea Manuela; Ita Margaretha Nainggolan; Linawati Hananta; Lucky Hartati Moehario
Indonesian Journal of Pharmacology and Therapy Vol 4 No 3 (2023)
Publisher : Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada and Indonesian Pharmacologist Association or Ikatan Farmakologi Indonesia (IKAFARI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/ijpther.8945

Abstract

Typhoid fever or commonly referred to as enteric fever is a systemic disease caused by Salmonella typhi. It often occurs in developing countries due to poor sanitation. Second-line antibiotics, including ciprofloxacin, have been widely used as the first choice treatment for typhoid fever. However, S. typhi has increased resistance to second-line antibiotics, so azithromycin has become an alternative treatment for the typhoid fever. This systematic review assessed the effectiveness of azithromycin and ciprofloxacin against typhoid fever in adults. This research used the PRISMA protocol with predefined Pubmed, Proquest, and EBSCO keywords. After removing duplicates and selecting studies according to inclusion and exclusion criterias, 17 studies about the effectiveness of azithromycin and ciprofloxacin in typhoid fever in adults from 1988-2020 were gathered. Studies were evaluated using JBI Critical Appraisal Tools. The results showed that administration of azithromycin and ciprofloxacin for typhoid fever yields average length of fever (3.5 d and 4.2 d) and average length of stay (9.3 d and 10 d), respectively. The susceptibility of S. typhi to azithromycin was 99.9%, whereas a significant decrease in its susceptibility to ciprofloxacin was observed in 2017-2020, from 4% to 2%. Azithromycin showed better effectiveness than ciprofloxacin in treating typhoid fever in adults based on S. typhi’s susceptibility, average length of fever and average length of stay from 17 studies reviewed.
Appropriate Concentration of Curcumin as a Growth Factor in Neural Stem Cells Titta Novianti; Muhamad Panji Januarsyah Kurniawan; Ita M Nainggolan
Al-Hayat: Journal of Biology and Applied Biology Vol. 7 No. 2 (2024)
Publisher : Fakultas Sains dan Teknologi, UIN Walisongo Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21580/ah.v7i2.20862

Abstract

The growth of Neural Stem Cell (NSC) in adult organisms is limited. Therefore, growth factors are needed to stimulate NSC cell proliferation and differentiation. Herbal Curcumin may be a growth factor. We promoted the growth of Cryopreserved Rat Cortical NSC cells with Curcumin (0.1 µM; 0.5 µM; 1 µM; 2 µM), DMSO, and synthetic growth factors (bFGF, TGF, and heparin). We analyzed the proliferation ability of NSCs by WST-1 assay, cell morphology, and expression of NCS cell marker genes (Nestin, MAP, and Sox2). Morphological analysis showed that cells reproduced big77 optimally at 0.5 µM. The one-way ANOVA and Tukey's posthoc test on the WST-1 test showed significant differences between 0.5 µMCurcumin and other treatment groups. Sox2, MAP-2, and Nestin gene expression peaked at 0.5 µM. The appropriate concentration of Curcumin to stimulate NSC proliferation is 0.5 µM. Herbal extract curcumin has the same effect as commercial growth factors and can substitute synthetic growth factors. Curcumin acts as a growth factor that stimulates the proliferation of mouse NSCs.